Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. (2021)

First Author: Voysey M

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S0140-6736(20)32661-1

PubMed Identifier: 33306989

Publication URI: http://europepmc.org/abstract/MED/33306989

Type: Journal Article/Review

Volume: 397

Parent Publication: Lancet (London, England)

Issue: 10269

ISSN: 0140-6736